Ledger.Open graph →

SEC Form D · filed December 11, 2024

Aarvik Therapeutics, Inc

Offering

$15.0M

Sold

$1.2M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

Hayward, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Mark K. Reddy · Hayward, CAExec · Director Sachdev Sidhu · Hayward, CADirector Anula Jayasuriya · Hayward, CADirector Jagath Reddy Junutula · Hayward, CAExec · Director Ram K. Reddy · Hayward, CADirector Richard Scheller · Hayward, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗